Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
98.44 EUR | -0.97% | -0.80% | -12.96% |
06-05 | Collective bargaining partners in the chemical industry adjourn again | DP |
05-31 | Wacker Chemie AG completed the acquisition of Assets of Bio Med Sciences Inc. | CI |
Sales 2024 * | 6.14B 6.58B 518B | Sales 2025 * | 6.6B 7.08B 557B | Capitalization | 4.95B 5.31B 417B |
---|---|---|---|---|---|
Net income 2024 * | 225M 241M 18.98B | Net income 2025 * | 413M 443M 34.84B | EV / Sales 2024 * | 0.85 x |
Net Debt 2024 * | 251M 270M 21.2B | Net Debt 2025 * | 197M 211M 16.62B | EV / Sales 2025 * | 0.78 x |
P/E ratio 2024 * |
22.3
x | P/E ratio 2025 * |
12.3
x | Employees | - |
Yield 2024 * |
2.48% | Yield 2025 * |
4.08% | Free-Float | 31.67% |
Latest transcript on Wacker Chemie AG
1 week | -0.80% | ||
Current month | -2.55% | ||
1 month | -1.29% | ||
3 months | -4.83% | ||
6 months | -9.96% | ||
Current year | -12.96% |
Managers | Title | Age | Since |
---|---|---|---|
Christian Hartel
CEO | Chief Executive Officer | 53 | 31/10/15 |
Jörg Hoffmann
IRC | Investor Relations Contact | - | - |
Thomas Renner
PRN | Corporate Officer/Principal | - | 31/12/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 73 | 07/05/08 | |
Matthias Biebl
BRD | Director/Board Member | 58 | 07/05/08 |
Susanne Weiss
BRD | Director/Board Member | 63 | 07/05/08 |
Date | Price | Change |
---|---|---|
11/06/24 | 98.68 | -0.72% |
10/06/24 | 99.4 | -0.40% |
07/06/24 | 99.8 | -0.45% |
06/06/24 | 100.2 | -0.69% |
05/06/24 | 101 | -0.15% |
Delayed Quote Börse Stuttgart, June 11, 2024 at 03:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.24% | 19.48B | |
+2.87% | 4.13B | |
+14.65% | 1.54B | |
-4.73% | 1.2B | |
+23.04% | 989M | |
-18.27% | 635M | |
-40.32% | 530M | |
-22.14% | 262M | |
-6.30% | 249M |
- Stock Market
- Equities
- WCH Stock
- WCH Stock